OPKO Health, Inc.
(NASDAQ : OPK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.17%46.508.1%$739.78m
AMGNAmgen Inc.
0.33%176.691.3%$505.23m
CELGCelgene Corporation
-0.01%91.751.3%$444.15m
GILDGilead Sciences, Inc.
-1.41%67.110.9%$405.67m
BIIBBiogen Inc.
-0.35%232.811.3%$386.33m
ILMNIllumina, Inc.
0.07%302.493.5%$336.00m
REGNRegeneron Pharmaceuticals, Inc.
-0.24%297.482.6%$277.49m
SRPTSarepta Therapeutics, Inc.
-2.53%152.9414.7%$203.59m
ALXNAlexion Pharmaceuticals, Inc.
0.68%123.872.0%$199.49m
VRTXVertex Pharmaceuticals Incorporated
0.20%176.731.9%$187.87m
EXASExact Sciences Corporation
-0.23%115.9224.1%$140.16m
AAgilent Technologies, Inc.
-1.13%69.751.6%$133.73m
INCYIncyte Corporation
-1.34%80.302.5%$114.54m
BLUEBluebird Bio, Inc.
-1.47%133.7614.3%$97.75m
BMRNBioMarin Pharmaceutical Inc.
-1.83%82.454.3%$87.72m

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.